(Q34585320)

3 August 2017

1 reference

title

Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands (English)

1 reference

3 August 2017

0 references

0 references

Wakefield AJ

1

1 reference

3 August 2017

Puleston JM

2

1 reference

3 August 2017

Montgomery SM

3

1 reference

3 August 2017

Anthony A

4

1 reference

3 August 2017

O'Leary JJ

5

1 reference

3 August 2017

Murch SH

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

16

1 reference

3 August 2017

4

1 reference

3 August 2017

663-674

1 reference

Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Complications of cirrhosis III. Hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Clinical effects of fenfluramine on children with autism: a review of the research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Peptide excretion in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Psychic disturbances in adult coeliac disease. I. Clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Neurological disorders associated with adult coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Does cryptic gluten sensitivity play a part in neurological illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Hunches on some biological factors in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Enterocolitis in children with developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Gastrointestinal abnormalities in children with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Abnormal intestinal permeability in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Hepatitis B vaccination and control of hepatitis B-related liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Putrescine as a source of instant energy in the small intestine of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Autism and Clostridium tetani.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Short-term benefit from oral vancomycin treatment of regressive-onset autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Speculations on similarities between autism and opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

A neurochemical theory of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Enkephalin-containing polypeptides are potent inhibitors of enkephalin degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Administered peptides inhibit the degradation of endogenous peptides. The dilemma of distinguishing direct from indirect effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Increased brain size and cellular content in infant rats treated with an opiate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

The brain in infantile autism: posterior fossa structures are abnormal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Histoanatomic observations of the brain in early infantile autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Autistic Syndromes and Diet: a follow‐up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

A Gluten-Free Diet as an Intervention for Autism and Associated Spectrum Disorders: Preliminary Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Naltrexone decreases self-injurious behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Opioid peptides and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

On the blood-brain barrier to peptides: [3H]beta-casomorphin-5 uptake by eighteen brain regions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: correlation with plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Opioid receptor ligands in human hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Sulphation deficit in "low-functioning" autistic children: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Free serotonin in plasma: autistic children and their first-degree relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Disruption of sulphated glycosaminoglycans in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Inflammatory bowel disease: psychiatric status of patients before and after disease onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Depressed lymphocyte responsiveness in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Reduced natural killer cell activity in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Antibodies to myelin basic protein in children with autistic behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Abnormal immune response to brain tissue antigen in the syndrome of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

A clinical study of 57 children with fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Linking etiologies in humans and animal models: studies of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

Opioid peptides and perinatal development: is beta-endorphin a natural teratogen? Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01206.X

10.1046/J.1365-2036.2002.01206.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference